COVID-19 cardiac injury: Implications for long-term surveillance and outcomes in survivors

Zheng, 2020, COVID-19 and the cardiovascular system, Nat Rev Cardiol, 17, 259, 10.1038/s41569-020-0360-5

Bhatraju, 2020, Covid-19 in critically Ill patients in the Seattle region—case series, N Engl J Med, 382, 2012, 10.1056/NEJMoa2004500

Shi

Siripanthong

Akhmerov, 2020, COVID-19 and the heart, Circ Res, 126, 1443, 10.1161/CIRCRESAHA.120.317055

Liu, 2020, The science underlying COVID-19: implications for the cardiovascular system, Circulation, 142, 68, 10.1161/CIRCULATIONAHA.120.047549

Chen, 2020, The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2, Cardiovasc Res, 116, 1097, 10.1093/cvr/cvaa078

Suthahar, 2017, From inflammation to fibrosis-molecular and cellular mechanisms of myocardial tissue remodelling and perspectives on differential treatment opportunities, Curr Heart Fail Rep, 14, 235, 10.1007/s11897-017-0343-y

Mitrani, 2018, Impact of nontraditional antiarrhythmic drugs on sudden cardiac death, 1084

Grein, 2020, Compassionate use of remdesivir for patients with severe Covid-19, N Engl J Med, 382, 2327, 10.1056/NEJMoa2007016

Chen, 2020, Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study, BMJ, 368, m1091, 10.1136/bmj.m1091

Guo

Bonow RO, Fonarow GC, O’Gara PT, Yancy CW. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality [published online ahead of print March 27, 2020]. JAMA Cardiol. https://doi.org/10.1001/jamacardio.2020.1105.

Inciardi

Atri, 2020, COVID-19 for the cardiologist: a current review of the virology, clinical epidemiology, cardiac and other clinical manifestations and potential therapeutic strategies, JACC Basic Transl Sci, 5, 518, 10.1016/j.jacbts.2020.04.002

Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet, 395, 497, 10.1016/S0140-6736(20)30183-5

Goyal, 2020, Clinical characteristics of Covid-19 in New York City, N Engl J Med, 382, 2372, 10.1056/NEJMc2010419

Richardson, 2020, Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area, JAMA, 323, 2052, 10.1001/jama.2020.6775

Oudit, 2009, SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS, Eur J Clin Invest, 39, 618, 10.1111/j.1365-2362.2009.02153.x

Zhou, 2020, Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study, Lancet, 395, 1054, 10.1016/S0140-6736(20)30566-3

Ruan, 2020, Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China, Intensive Care Med, 46, 846, 10.1007/s00134-020-05991-x

Tavazzi, 2020, Myocardial localization of coronavirus in COVID-19 cardiogenic shock, Eur J Heart Fail, 22, 911, 10.1002/ejhf.1828

Capecchi, 2019, Autoimmune and inflammatory K+ channelopathies in cardiac arrhythmias: clinical evidence and molecular mechanisms, Heart Rhythm, 16, 1273, 10.1016/j.hrthm.2019.02.017

Bangalore, 2020, ST-segment elevation in patients with Covid-19—a case series, N Engl J Med, 82, 2478, 10.1056/NEJMc2009020

Kwong, 2018, Acute myocardial infarction after laboratory-confirmed influenza infection, N Engl J Med, 378, 345, 10.1056/NEJMoa1702090

Mahmud

Chapman, 2018, Long-term outcomes in patients with type 2 myocardial infarction and myocardial injury, Circulation, 137, 1236, 10.1161/CIRCULATIONAHA.117.031806

Scally, 2018, Persistent long-term structural, functional, and metabolic changes after stress-induced (takotsubo) cardiomyopathy, Circulation, 137, 1039, 10.1161/CIRCULATIONAHA.117.031841

Jesel, 2018, Ventricular arrhythmias and sudden cardiac arrest in Takotsubo cardiomyopathy: incidence, predictive factors, and clinical implications, Heart Rhythm, 15, 1171, 10.1016/j.hrthm.2018.04.002

Heusch, 2018, Coronary microembolization and microvascular dysfunction, Int J Cardiol, 258, 17, 10.1016/j.ijcard.2018.02.010

Marc-Alexander, 2018, Predictors of long-term outcome in patients with biopsy proven inflammatory cardiomyopathy, J Geriatr Cardiol, 15, 363

Peretto, 2020, Ventricular arrhythmias in myocarditis: characterization and relationships with myocardial inflammation, J Am Coll Cardiol, 75, 1046, 10.1016/j.jacc.2020.01.036

Chang, 2017, Heart failure and mortality of adult survivors from acute myocarditis requiring intensive care treatment—a nationwide cohort study, Int J Med Sci, 14, 1241, 10.7150/ijms.20618

Magnani, 2006, Survival in biopsy-proven myocarditis: a long-term retrospective analysis of the histopathologic, clinical, and hemodynamic predictors, Am Heart J, 151, 463, 10.1016/j.ahj.2005.03.037

Anzini, 2013, Long-term evolution and prognostic stratification of biopsy-proven active myocarditis, Circulation, 128, 2384, 10.1161/CIRCULATIONAHA.113.003092

Prochnau, 2010, Successful use of a wearable cardioverter-defibrillator in myocarditis with normal ejection fraction, Clin Res Cardiol, 99, 129, 10.1007/s00392-009-0093-2

Junttila, 2016, Temporal trends in the clinical and pathological characteristics of victims of sudden cardiac death in the absence of previously identified heart disease, Circ Arrhythm Electrophysiol, 9, 10.1161/CIRCEP.115.003723

Tseng, 2018, Prospective countywide surveillance and autopsy characterization of sudden cardiac death: POST SCD study, Circulation, 137, 2689, 10.1161/CIRCULATIONAHA.117.033427

Maron, 2009, Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006, Circulation, 119, 1085, 10.1161/CIRCULATIONAHA.108.804617

Begieneman, 2016, Ventricular myocarditis coincides with atrial myocarditis in patients, Cardiovasc Pathol, 25, 141, 10.1016/j.carpath.2015.12.001

Blagova, 2016, Myocardial biopsy in “idiopathic” atrial fibrillation and other arrhythmias: nosological diagnosis, clinical and morphological parallels, and treatment, J Atr Fibrillation, 9, 1414

Chang, 2016, The association between influenza infection, vaccination, and atrial fibrillation: a nationwide case-control study, Heart Rhythm, 13, 1189, 10.1016/j.hrthm.2016.01.026

Malavazos, 2020, Targeting the adipose tissue in COVID-19, Obesity, 28, 1178, 10.1002/oby.22844

Packer, 2018, Epicardial adipose tissue may mediate deleterious effects of obesity and inflammation on the myocardium, J Am Coll Cardiol, 71, 2360, 10.1016/j.jacc.2018.03.509

Goeller, 2018, Epicardial adipose tissue density and volume are related to subclinical atherosclerosis, inflammation and major adverse cardiac events in asymptomatic subjects, J Cardiovasc Comput Tomogr, 12, 67, 10.1016/j.jcct.2017.11.007